Ecofibre Limited in brief
Ecofibre Limited is a listed company in the Pharmaceutical industry, based in Australia. Its last known market value was $38 M (January 2024); there is no current figure. In its latest reported year it had sales of $21 M and a net loss of $5 M. Its shares trade under the symbol EOF.AX (ASX).
Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.
About Ecofibre Limited
Ecofibre Limited (also abbreviated as Ecofibre or EOF) is an Australian listed biotechnology company that produces and sells hemp derived products to consumers and retailers in the United States and Australia. The company's products include cannabinoid (CBD) oil and nutraceuticals as well as hemp derived food and textiles.
Ecofibre operates through its U.S. locations in Georgetown, Kentucky and Greensboro, North Carolina and its Australian location in Newcastle, New South Wales.
Ecofibre listed on the Australian Securities Exchange in March 2019 through an initial public offering, raising A$20 million in equity capital.
From Wikipedia: read the full article · text available under CC BY-SA 4.0
Ecofibre Limited timeline
- 2019
- 🔔Initial public offering on Australian Securities Exchange as EOF
Events of Ecofibre Limited from Wikidata. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.
Market cap history
World rank over time
Rank in Australia: #216 (Jan 2020) · #246 (Jan 2021) · #547 (Jan 2022) · #632 (Dec 2022) · #704 (Jul 2023) · #732 (Jan 2024)
Annual results
- Revenue
- $21 M
- Operating income
- —
- Net income
- $-5 M
How Ecofibre Limited compares in Pharmaceutical
- Revenue$21 M · higher than 9% of 324
- Net margin-24.3% · higher than 13% of 313
Peer comparison · Pharmaceutical
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| Ecofibre Limited🇦🇺 | $38 M | — | -24.3% | — |
| Eli Lilly and Company🇺🇸 | $1.20 T | 43.4× | 31.9% | +44.7% |
| Johnson & Johnson🇺🇸 | $652.5 B | 40.5× | 16.2% | +6.0% |
| AbbVie Inc.🇺🇸 | $514.0 B | 49.7× | 15.7% | +8.6% |
| Roche Holding AG🇨🇭 | $370.3 B | 29.1× | 19.0% | — |
| Merck & Co., Inc.🇺🇸 | $359.8 B | 146.7× | 3.6% | +1.3% |
| Novartis AG🇨🇭 | $286.8 B | 20.5× | 24.7% | — |
| Amgen Inc.🇺🇸 | $249.2 B | 26.5× | 24.1% | +9.9% |
| AstraZeneca PLC🇬🇧 | $242.6 B | 23.7× | 17.4% | +8.6% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Questions people ask
Compare head to head
Similar companies by size and industry
- Eli Lilly and Company$1.20 T
- Johnson & Johnson$652.5 B
- AbbVie Inc.$514.0 B
- Roche Holding AG$370.3 B
- Merck & Co., Inc.$359.8 B
- Novartis AG$286.8 B
Sources and freshness
- Market cap:
- Jan 5, 2024 (last known)
- Profile updated:
- Nov 15, 2026
Figures from value.today research, Wikipedia.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at Ecofibre Limited? Verify and update this profile — free
Show Ecofibre Limited's ranking or a chart on your website Get the badge
The badge updates itself as the ranking changes.